Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-myeloablative allogeneic hematopoietic stem cell transplantation from HLA-identical sibling for metastatic soft tissue sarcomas
2004-001035-32Phase 2Terminated
- Sponsor
- Italian Sarcoma Group
- Start
- Mar 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, cyclophosphamide, fludarabine in soft tissue sarcoma (STS), sponsored by Italian Sarcoma Group. Started Mar 2007; status: terminated.
02
Drugs
thiotepacyclophosphamidefludarabine
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2004-001035-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001035-32.